Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCATCo Regulatory News (CAT)

  • This share is currently suspended. It was suspended at a price of 37.50
  • There is currently no data for CAT

EPT Disclosure

12 Jun 2006 11:34

Deutsche Bank AG London12 June 2006 FORM 38.5(a) DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY (Rule 38.5(a) of the Takeover Code) 1. KEY INFORMATION Name of exempt principal trader Deutsche Bank AG London Company dealt in Cambridge Antibody Technology Group Plc Class of relevant security to which the Ordinarydealings being disclosed relate (Note 1) Date of dealing 09/06/2006 2. DEALINGS (Note 2) (a) Purchases and sales Total number of securities purchased Highest price paid (Note 3) Lowest price paid (Note 3) 5,508 £13.105 £13.0659 Total number of securities sold Highest price received (Note 3) Lowest price received (Note 3) 9,016 £13.085 £13.0659 (b) Derivatives transactions (other than options) Product name, Long/short (Note 4) Number of securities (Note 5) Price per unit (Note 3)e.g. CFD CFD Short 4,508 £13.066 (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product name, Writing, selling, Number of securities Exercise Type, e.g. Expiry Option money purchasing, to which the option American,e.g. call option varying etc. relates (Note 5) price European etc. Date paid/received per unit (Note 3) (ii) Exercising Product name, e.g. call option Number of securities Exercise price per unit (Note 3) 3. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relatingto the voting rights of any relevant securities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form isreferenced. If none, this should be stated. NONE Date of disclosure 12/06/2006 Contact name Kelly-Jade Ledwich Telephone number 020 7545 7804 Name of offeree/offeror with which connected AstraZeneca PlcNature of connection (Note 6) Adviser to the offeror Notes The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
12th Oct 201712:44 pmRNSHolding(s) in Company
4th Oct 20172:00 pmRNSAGM Statement
2nd Oct 20177:00 amRNSIssue of Equity and Portfolio Update
21st Sep 20177:00 amRNSNet Asset Value(s)
29th Aug 201712:49 pmRNSStatement re Hurricane Harvey
18th Aug 20177:00 amRNSHalf-year Report
17th Aug 201711:54 amRNSHolding(s) in Company
17th Aug 20177:00 amRNSNet Asset Value(s)
20th Jul 20177:00 amRNSNet Asset Value(s)
21st Jun 20177:00 amRNSInvestment Manager - Executive Update
19th Jun 20177:00 amRNSNet Asset Value(s)
5th Jun 20173:20 pmRNSHolding(s) in Company
1st Jun 20176:25 pmRNSHolding(s) in Company
1st Jun 20174:43 pmRNSHolding(s) in Company
25th May 20175:14 pmRNSHolding(s) in Company
25th May 20172:51 pmRNSIssue of Equity
16th May 20177:00 amRNSNet Asset Value(s) and Issuance of Shares
15th May 20177:00 amRNSProposed Capital Raise
11th May 20178:00 amRNSConversion of Securities
19th Apr 20177:00 amRNSNet Asset Value(s)
6th Apr 20172:00 pmRNSAGM Statement
30th Mar 20172:25 pmRNSDirector/PDMR Shareholding
21st Mar 20174:48 pmRNSHolding(s) in Company
16th Mar 201711:33 amRNSNet Asset Value(s)
2nd Mar 20177:00 amRNSDirectorate Change
2nd Mar 20177:00 amRNSAnnual Financial Report
27th Feb 20177:00 amRNSNet Asset Value(s)
31st Jan 20177:00 amRNSPortfolio Update
26th Jan 20171:17 pmRNSDividend Declaration
20th Jan 20177:00 amRNSNet Asset Value and Portfolio Update
19th Dec 20167:00 amRNSNet Asset Value(s)
18th Nov 20167:00 amRNSTender Offer
14th Nov 20167:00 amRNSNet Asset Value(s)
8th Nov 20165:27 pmRNSHolding(s) in Company
20th Oct 20161:51 pmRNSHolding(s) in Company
19th Oct 20167:00 amRNSNet Asset Value(s)
19th Sep 20167:00 amRNSNet Asset Value and Portfolio Update
22nd Aug 20167:00 amRNSNet Asset Value(s)
15th Aug 20167:00 amRNSDirector/PDMR Shareholding
12th Aug 20167:00 amRNSHalf-year Report
19th Jul 20167:00 amRNSNet Asset Value(s)
17th Jun 20163:58 pmRNSNet Asset Value(s)
16th May 201612:57 pmRNSNet Asset Value(s)
10th May 20167:00 amRNSDirectorate Change
19th Apr 20167:00 amRNSNet Asset Value(s)
24th Mar 20165:35 pmRNSIssue of Equity
22nd Mar 201612:46 pmRNSResult of AGM
18th Mar 20167:00 amRNSNet Asset Value(s)
14th Mar 20161:18 pmRNSHolding(s) in Company
7th Mar 20167:00 amRNSSide-Pocket Investment Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.